Bulletin
Investor Alert

23andMe Holding Co.

NAS: ME

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Feb 3, 2023, 7:32 p.m.

ME
/zigman2/quotes/222659849/composite

$

2.73

Change

+0.04 +1.49%

Volume

Volume 38,490

Quotes are delayed by 20 min

/zigman2/quotes/222659849/composite

Previous close

$ 2.75

$ 2.69

Change

-0.06 -2.18%

Day low

Day high

$2.64

$2.80

Open

52 week low

52 week high

$2.02

$6.31

Open

Patrick Shuao-Fong Chung

Patrick Shuao-Fong Chung founded WRLD3D Ltd. He is Partner at Xfund Management Co. LLC. He is also on the board of 23andMe, Inc., Philo, Inc. and 23andMe Holding Co. and Member of New York State Bar Association, Member of Massachusetts Bar Association and Associate of Creative Destruction Lab.

In the past Mr. Chung occupied the position of Principal at McKinsey & Co., Inc., Partner at NEA Management Co. LLC, Principal at Zefer Corp. and Director at WRLD3D Ltd.

He received a graduate degree from Harvard Law School, an MBA from Harvard Business School, an undergraduate degree from Harvard College and a graduate degree from the University of Oxford.

Transactions

Date Shares Transaction Value
09/06/2022 3,414   Award at $3.08 per share. 10,515
09/06/2022 14,633   Award at $0 per share. 0
08/25/2022 18,811   Award at $3.03 per share. 56,997
08/25/2022 57,755   Award at $0 per share. 0
09/14/2021 18,421   Award at $0 per share. 0

Officers and Executives

Ms. Anne E. Wojcicki
President, Chief Executive Officer & Director
Mr. Joseph Selsavage
Chief Financial & Accounting Officer
Mr. Steve Lemon
Vice President-Engineering
Dr. Joyce Tung
Vice President-Research
Dr. L. Okey Onyejekwe
VP-Healthcare Operations & Medical Affairs
Dr. Joseph R. Arron
Chief Scientific Officer
Ms. Kathy L. Hibbs
Secretary & Chief Administrative Officer
Dr. Kenneth J. Hillan
Chief Therapeutics Officer
Mr. Adam Auton
Vice President-Human Genetics
Mr. David Baker
Chief Security Officer
Dr. Arnab Chowdry
Vice President-Genetic Technology
Mr. Kent Hillyer
Vice President-Customer Care
Dr. Jennifer Low
Head-Therapeutics Development
Mr. Mike Polcari
Vice President & Chief Architect
Dr. William Richards
Vice President-Drug Discovery
Dr. Monica Viziano
VP-Portfolio Strategy & Alliance Management
Mr. Paul Johnson
Chief Operating Officer-Consumer
Mr. Daniel Chu
Chief Product Officer
Mr. Evan M. Lovell
Director
Dr. Richard H. Scheller
Director
Ms. Tracy Keim
Vice President-Consumer Marketing & Brand
Dr. D. Wade Walke
Vice President-Investor Relations
Ms. Jacquie Cooke Haggarty
General Counsel & Privacy Officer
Mr. Roelof Frederik Botha
Independent Director
Mr. Patrick Shuao-Fong Chung
Independent Director
Mr. Peter J. Taylor
Independent Director
Dr. Valerie C. Montgomery Rice
Independent Director
Dr. Sandra Rae Hernández
Independent Director
Mr. Neal Mohan
Independent Director
Link to MarketWatch's Slice.